Kevin M. Brennan, SVP, FINANCE AND ACCOUNTING at Xilio Therapeutics, Inc. (XLO), sold 3,652 shares at $0.64 ($2K) on 2026-01-02, disclosed to the SEC on 2026-01-05.
Open-market sale of $2k XLO by SVP, FINANCE AND ACCOUNTING. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.64 | 1,826 | $1K | 49.9% |
| 2 | $0.64 | 1,826 | $1K | 50.1% |
| Total | $0.64 avg | 3,652 | $2K | 100% |